bpc-157 human clinical trials safety review Preclinical evaluation of body protective compound-157, a potential drug for treating various wounds bpc-157 human clinical trials evidence

(NOTE: There is an ongoing debate about whether 5-Amino 1MQ should be classified as a small molecule or a peptide, but thats a discussion far beyond the scope of this article) It was discovered in 2017 by researchers at the University of Texas who were attempting to discover small, selective, and membrane-permeable inhibitors of an enzyme called nicotinamide N -methyltransferase (NNMT)

A topical numbing cream will be applied prior to the injection if requested

Research suggests this dual action creates cellular conditions that favor energy expenditure over energy storage, giving researchers a tool to study metabolic switching mechanisms

PubMed record Esposito S, et al

Functional improvement